[Expression and significance of Tim-3 on peripheral blood monocytes in patients with chronic hepatitis B].

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

Department of Infectious Diseases, Affiliated Hospital, Xuzhou Medical College, Jiangsu 221002, China.

Published: July 2013

Objective: To detect T cell immunoglobulin and mucin domain-containing molecule 3(Tim-3) expression on peripheral blood monocyts (PBMs) and explore its effect on inflammatory cytokines production of PBMs in patients with chronic hepatitis B (CHB).

Methods: The expression of Tim-3 protein and mRNA on PBM subsets was respectively determined using flow cytometry and real-time quantitative RT-PCR (qRT-PCR) in CHB patients at different phases. After PBMs were stimulated with both recombinant human galectin-9 and lipopolysaccharide (LPS) in active CHB patients, the supernatants were collected to measure the levels of proinflammatory factors including TNF-α, IL-1β and IL-6 by ELISA.

Results: Compared with healthy controls and CHB patients at immune active (IA) phase, the expression of Tim-3 was significantly up-regulated in PBMs of CHB patients at immune tolerance (IT) phase (P<0.01). The level of Tim-3 expression on both CD14(+);CD16-; and CD14(+);CD16(+); monocyte subsets of CHB patients at IT phase was significantly higher than that of the CHB patients at IA phase and of healthy controls (P<0.05). qRT-PCR further demonstrated that the level of Tim-3 mRNA on monocytes of CHB patients at IA phase was also higher than that of healthy controls (P=0.040). There was a positive correlation between the expression of Tim-3 on CD14(+); monocytes and serum ALT level in IA CHB patients (r=0.362, P=0.028). The levels of proinflammatory factors in supernatants, such as TNF-α, IL-1β and IL-6 increased significantly in monocytes stimulated by LPS and galectin-9, compared with ones by LPS alone.

Conclusion: Tim-3 expression, which is up-regulated on PBMs of CHB patients, is negatively correlated to the level of ALT in sera of IA CHB patients, and Tim-3/galectin-9 pathway might promote proinflammatory factors production of monocytes stimulated with LPS.

Download full-text PDF

Source

Publication Analysis

Top Keywords

chb patients
16
peripheral blood
8
patients chronic
8
chronic hepatitis
8
expression tim-3
8
patients immune
8
patients
6
[expression significance
4
significance tim-3
4
tim-3 peripheral
4

Similar Publications

C-X-C chemokine receptor type 5CD8 T cells as immune regulators in hepatitis Be antigen-positive chronic hepatitis B under interferon-alpha treatment.

World J Gastroenterol

January 2025

Institute of Hepatology and Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China.

Background: C-X-C chemokine receptor type 5 (CXCR5)CD8 T cells represent a unique immune subset with dual roles, functioning as cytotoxic cells in persistent viral infections while promoting B cell responses. Despite their importance, the specific role of CXCR5CD8 T cells in chronic hepatitis B (CHB), particularly during interferon-alpha (IFN-α) treatment, is not fully understood. This study aims to elucidate the relationship between CXCR5CD8 T cells and sustained serologic response (SR) in patients undergoing 48 weeks of pegylated IFN-α (peg-IFN-α) treatment for CHB.

View Article and Find Full Text PDF

Neuromuscular Electrostimulation Increases Microcirculatory Flux in Mixed Etiology Leg Ulcers.

Adv Skin Wound Care

January 2025

Keith Gordon Harding, Mb ChB, CBE, FRCGP, FRCP, FRCS, FLSW, is Professor Emeritus Cardiff University, Cardiff, Wales; Adjunct Professor Monash University Malaysia, Subang Jaya, Selangor, Malaysia; and Co-Founder and Editor in Chief of the International Wound Journal. Melissa Blow, BSc, is Principal Podiatrist, South East Wales Vascular Network, Aneurin Bevan University Health Board, Cardiff, Wales. Faye Ashton, BSc, is Vascular Research Nurse, Leicester Biomedical Research Centre, Glenfield University Hospital, Leicester, United Kingdom. David Bosanquet, MD, is Consultant Vascular Surgeon, South East Wales Vascular Network, Aneurin Bevan University Health Board. Acknowledgments: The authors acknowledge the assistance of Firstkind Ltd, Hawk House, Peregrine Business Park, Gomm Road, High Wycombe, United Kingdom HP13 7DL for sponsoring the study (grant ref: FSK-SPECKLE-001) and provided the NMES devices for the trial. Keith Harding has received payments for consulting work from Firstkind Ltd. The authors have disclosed no other financial relationships related to this article. Submitted November 28, 2023; accepted in revised form April 17, 2024.

Objective: To determine if intermittent neuromuscular electrostimulation (NMES) of the common peroneal nerve increases microvascular flow and pulsatility in and around the wound bed of patients with combined venous and arterial etiology.

Methods: Seven consenting participants presenting with mixed etiology leg ulcers participated in this study. Microvascular flow and pulsatility was measured in the wound bed and in the skin surrounding the wound using laser speckle contrast imaging.

View Article and Find Full Text PDF

Viral hepatitis B is infamous for being contracted in young adulthood and adolescence, as high-risk behaviors like unprotected sexual intercourse and intravenous drug abuse are common. Most infections caused by the hepatitis B virus (HBV) are cleared without any long-term sequelae, but some may persist and cause chronic hepatitis B (CHB). This chronicity may produce a state of prolonged inflammation and significantly increase the risk of developing colorectal adenomas (CRA) and colorectal carcinomas (CRC).

View Article and Find Full Text PDF

Background: Covalently closed circular DNA (cccDNA) is a stable, episomal form of HBV DNA. cccDNA is a true marker for the intrahepatic events in controlled CHB infection. Quantifying cccDNA is critical for monitoring disease progression, and efficacy of anti-viral therapies.

View Article and Find Full Text PDF

Background/aims: Besifovir (BSV) showed comparable antiviral activity superior safety profiles to tenofovir disoproxil fumarate (TDF) in treatment-naïve chronic hepatitis B (CHB). However, no data are available regarding the antiviral efficacy and safety of BSV in patients with CHB who switched from long-term TDF to BSV. This study aimed to evaluate the outcome of a 48-week BSV therapy in patients with CHB who switched from long-term TDF treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!